Full Text View
Tabular View
No Study Results Posted
Related Studies
IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (Study P04103AM3)
This study is currently recruiting participants.
Study NCT00202878   Information provided by Schering-Plough
First Received: September 13, 2005   Last Updated: November 24, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypercholesterolemia
Myocardial Infarction
Additional conditions recognized in this trial
Acute Coronary Syndrome
Infarction
Syndrome
More general conditions related to this trial
Cardiovascular Diseases
Disease
Dyslipidemias
Heart Diseases
Hyperlipidemias
Ischemia
Lipid Metabolism Disorders
Metabolic Diseases
Myocardial Ischemia
Necrosis
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
ezetimibe/simvastatin
simvastatin
Additional drug interventions recognized in this trial
Ezetimibe
More general drug interventions related to this trial
Anticholesteremic Agents
Antilipemic Agents
Antimetabolites
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Schering-Plough
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services